3D Health Solutions

3D Health Solutions is a private, early-stage biotech firm leveraging proprietary canine organoid technology to model organ function for drug and nutraceutical screening. Founded in 2015, the company operates a hybrid business model offering CRO services, model co-development, and future product sales, with backing from key U.S. government agencies. Its strategic partnerships with the FDA's Center for Veterinary Medicine and leading industry players position it at the intersection of digital health, veterinary medicine, and the global push for alternative testing methods under the Modernization Act 2.0.

Canine organoid cell culture platform for intestine, liver, pancreas, kidney, and heart, derived from adult stem cells to model organ structure and function for screening.

3DHS operates in the broader organoid and alternative testing market, competing with human organoid specialists and traditional 2D cell culture providers. Its primary competitive advantage is its specific focus on and expertise in canine models, validated by partnerships with the FDA and NCI, creating a defensible niche in veterinary and translational research.